We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App

Neural Network Recognizes Breast Cancer on Histological Samples With 100% Accuracy

By LabMedica International staff writers
Posted on 02 Feb 2024
Print article
Image: The “attentive” neural network recognizes breast cancer with 99.6% accuracy (Photo courtesy of RUDN University)
Image: The “attentive” neural network recognizes breast cancer with 99.6% accuracy (Photo courtesy of RUDN University)

The likelihood of a favorable outcome for a breast cancer patient is greatly influenced by the stage at which the cancer is diagnosed. Histological examination is the benchmark for diagnosis, but its reliability can be affected by subjective interpretations and the quality of the tissue sample. Inaccuracies in these examinations can lead to incorrect diagnoses. Now, a team of mathematicians has developed a machine learning model that significantly enhances the accuracy of identifying cancer in histological images. The highlight of this model is the incorporation of an additional module that boosts the neural network's "attention" capability, enabling it to achieve near-perfect accuracy.

The mathematicians at RUDN University (Moscow, Russia) conducted tests on several convolutional neural networks and supplemented them with two convolutional attention modules. These modules are crucial for detecting objects within images. The model underwent training and testing using the BreakHis dataset, which comprises nearly 10,000 histological images at various scales, sourced from 82 patients. The most impressive performance came from a model that combined the DenseNet211 convolutional network with the attention modules, achieving a remarkable accuracy rate of 99.6%. The research team noted that the detection of cancerous formations is affected by image scale. This is because images differ in quality at various zoom levels, and cancerous formations appear differently. Therefore, during practical application, selecting the appropriate scale for image analysis must be a critical consideration.

“Computer classification of histological images will reduce the burden on doctors and increase the accuracy of tests. Such technologies will improve the treatment and diagnosis of breast cancer. Deep learning methods have shown promising results in medical image analysis problems in recent years,” said Ammar Muthanna, Ph.D., Director of the Scientific Center for Modeling Wireless 5G Networks at RUDN University. “The attention modules in the model improved feature extraction and the overall performance of the model. With their help, the model focused on significant areas of the image and highlighted the necessary information. It shows the importance of attention mechanisms in the analysis of medical images.”

Related Links:
RUDN University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article


Molecular Diagnostics

view channel
Image: Prostate cancer cell image taken using a scanning electron microscope (Photo courtesy of LRI EM Unit)

New Discoveries of Prostate Cancer Evolution Pave Way for Genetic Test

Prostate cancer ranks as one of the most common cancers affecting men, and while it accounts for a significant number of male cancer fatalities, many men live with it rather than die from it.... Read more


view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more


view channel
Image: The companies will develop genetic testing systems based on capillary electrophoresis sequencers (Photo courtesy of 123RF)

Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems

Sysmex Corporation (Kobe, Japan) and Hitachi High-Tech Corporation (Tokyo, Japan) have entered into a collaboration for the development of genetic testing systems using capillary electrophoresis sequencers... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.